Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Investigating the mechanism of constitutive activation of PKG Ib R177Q in thoracic aortic disease
EF 2019-20
Résumé
"Protein Kinase G (PKG) is a major regulator of smooth muscle tone and its malfunction can cause cardiac disorders. Specifically, a genetic mutation (R177Q) in its cyclic nucleotide binding domain A (CBD-A) renders PKG I constitutively active, resulting in thoracic aortic aneurysms (TAA) and lethal acute aortic dissections (AAD). The function of PKG CBD-A is not fully understood. Additionally, the molecular basis of the R177Q disease phenotype must be elucidated to develop medical interventions. The goal of this project is to determine the mechanism of PKG Ib CBD-A R177Q constitutive activation in thoracic aortic disease. The R177Q mutant exhibits negligible binding with cyclic guanosine monophosphate (cGMP). It is thus hypothesized that the mutation changes CBD-A structure such that interactions between the regulatory and catalytic regions are perturbed, abolishing auto-inhibition of kinase activity. To test this hypothesis, nuclear magnetic resonance (NMR) spectroscopy will be used. 3D experiments are the foundation of this analysis. Subsequent 2D experiments of both wildtype (wt) and mutant (mut) CBD-A will identify residues involved in ligand binding and conformational changes. Chemical shift projection analysis will reveal mutant residues shifted towards activation or inactivation; chemical shift covariance analysis will unveil key allosteric sites which will be confirmed using full-length PKG Ib. Finally, NMR relaxation methods will be used to characterize R177Q protein dynamics and their effect on protein function. In this manner, the molecular basis of PKG CBD-A R177Q's constitutive activation will be elucidated. These findings will be significant in informing drug design to ameliorate TAA and in advancing the current understanding of cGMP-dependent signalling."
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
428682
Name
Ahmed Alveena
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the mechanism of constitutive activation of PKG Ib R177Q in thoracic aortic disease
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acute Aortic Dissections; Allostery; Biomolecular Nmr; Cgmp; Cgmp-Dependent Protein Kinase; Cyclic Nucleotide Signalling; Drug Design; Protein Dynamics; Structural Determination; Thoracic Aortic Aneurysms
Abstract
"Protein Kinase G (PKG) is a major regulator of smooth muscle tone and its malfunction can cause cardiac disorders. Specifically, a genetic mutation (R177Q) in its cyclic nucleotide binding domain A (CBD-A) renders PKG I constitutively active, resulting in thoracic aortic aneurysms (TAA) and lethal acute aortic dissections (AAD). The function of PKG CBD-A is not fully understood. Additionally, the molecular basis of the R177Q disease phenotype must be elucidated to develop medical interventions. The goal of this project is to determine the mechanism of PKG Ib CBD-A R177Q constitutive activation in thoracic aortic disease. The R177Q mutant exhibits negligible binding with cyclic guanosine monophosphate (cGMP). It is thus hypothesized that the mutation changes CBD-A structure such that interactions between the regulatory and catalytic regions are perturbed, abolishing auto-inhibition of kinase activity. To test this hypothesis, nuclear magnetic resonance (NMR) spectroscopy will be used. 3D experiments are the foundation of this analysis. Subsequent 2D experiments of both wildtype (wt) and mutant (mut) CBD-A will identify residues involved in ligand binding and conformational changes. Chemical shift projection analysis will reveal mutant residues shifted towards activation or inactivation; chemical shift covariance analysis will unveil key allosteric sites which will be confirmed using full-length PKG Ib. Finally, NMR relaxation methods will be used to characterize R177Q protein dynamics and their effect on protein function. In this manner, the molecular basis of PKG CBD-A R177Q's constitutive activation will be elucidated. These findings will be significant in informing drug design to ameliorate TAA and in advancing the current understanding of cGMP-dependent signalling."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ahmed, Alveena
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~